OVERVIEW

Computed Tomography (CT) Findings for Lung Adenocarcinoma Treated With EGFR-TKI is organized by American Roentgen Ray Society (ARRS) and will be held during Dec 21, 2017 - Dec 20, 2020.

The target audience for this medical event is readers of the AJR and radiologists at all training levels with an interest in the diagnosis and treatment of lung cancer. This CME Conference has been approved for a maximum of 1 AMA PRA Category 1 Credit(s).

Conference Description :
AJR articles fulfill educational needs at all practice levels by addressing new research and studies, reviewing standards of care and addressing clinical practice and educational needs. Needs sources for the AJR include clinical practice guidelines, peer-reviewed literature, and expert-defined needs.

Conference Objectives are :
• Discuss two adverse prognostic CT findings in patients with advanced-stage lung adenocarcinoma which are receiving epidermal growth factor (EGFR) -tyrosine kinase inhibitor (TKI) therapy as first-line therapy.
• Describe current treatment strategies for advanced stage primary lung adenocarcinoma and the likelihood of response to EGFR-TKI therapy.

Additional details will be posted as soon as they are available.

Credits
  • 1 CME
  • SPECIALITIES

    Oncology

    RELATED ONLINE COURSES